Results 121 to 130 of about 10,054 (222)
Cutting Edge: Biomarkers for Chronic Spontaneous Urticaria
Chronic spontaneous urticaria (CSU) is defined by the appearance of wheals and a variable presence of angioedema which persists for at least 6 weeks. It represents the most common subtype of chronic urticaria and is gaining importance in civil society ...
Enrico Heffler +4 more
core +1 more source
Diagnostic and Therapeutic Approach of Chronic Spontaneous Urticaria: Recommendations in Portugal [PDF]
Chronic spontaneous urticaria is a complex disorder, of unclear etiology, easily diagnosed although often difficult to treat. It has a significant impact on the patients' quality of life and results in high direct and indirect costs.
COSTA, C +3 more
core +1 more source
ABSTRACT Pityriasis lichenoides (PL) is a benign, self‐limiting inflammatory condition, characterized by the appearance of papular, scaly, or necrotic lesions. Despite the rare incidence, clinicians should suspect its diagnosis in the presence of specific skin lesions and epidemiological contexts, as suggested by its association with infections and/or ...
Gregorio Serra +7 more
wiley +1 more source
Basophil Activation Test identifies the patients with Chronic Spontaneous Urticaria suffering the most active disease [PDF]
The basophil activation test showing CD63 up regulation could be a specific and sensitive in vitro complementary text to the in vivo autologous serum skin test for the activity assessment of the patients suffering autoimmune chronic spontaneous urticaria.
Mojal, Sergio +16 more
core +1 more source
BRAF inhibitors and MEK inhibitors (MEKi) have reshaped the treatment of BRAFV600‐mutant malignancies; however, cutaneous adverse drug reactions (ADRs) remain a frequent and clinically impactful toxicity. Although clinical trials provide insight into their safety profiles, real‐world data on dermatologic ADRs are limited.
Natalia Sauer +3 more
wiley +1 more source
Chronic spontaneous urticaria: an autoimmune disease? A revision of the literature
The cause of chronic spontaneous urticaria has been an enigma for decades, but the recognition of functional autoantibodies in some patients with the spontaneous chronic urticaria has opened up a new concept of autoimmune urticaria.
SEIDITA, Aurelio +4 more
core +1 more source
ABSTRACT Purpose To quantify the real‐world use and describe characteristics of paediatric patients initiating biologic medicines for immune‐mediated inflammatory diseases (IMIDs). Methods Dispensing claims for Australians aged less than 18 years were used to examine uptake and use trends of nine biologic medicines used for the treatment of IMIDs. A 15%
Jun Ni Ho +6 more
wiley +1 more source
Broadening the View: Substance P and Its Metabolism in Pruritus‐Related Diseases
ABSTRACT Chronic pruritus is a debilitating symptom accompanying numerous inflammatory skin diseases and remains a major therapeutic challenge. Neurogenic inflammation plays a central role in its pathogenesis, with the tachykinin substance P acting as a key mediator at the interface of the nervous system, immune cells, and cutaneous tissues.
Thomas Walter, Bjoern B. Burckhardt
wiley +1 more source
Ligelizumab re‐treatment in CSU patients showed sustained efficacy and tolerability. Over 50% achieved symptom control (UAS7 ≤ 6) by Week 12; benefits maintained through Week 52. No new safety signals observed; aligns with prior PEARL trial outcomes. CSU, chronic spontaneous urticaria; mg, milligram; q4w, every 4 weeks; UAS, urticaria activity score ...
Ana M. Gimenez‐Arnau +22 more
wiley +1 more source
Endotypes of chronic spontaneous urticaria and angioedema
The current understanding of chronic spontaneous urticaria (CSU) suggests that a complex network of inflammatory pathways is involved in its pathogenesis. Recent development highlighted autoimmunity as one of the key pathogenic mechanisms of CSU. Two endotypes, type I autoallergic (associated with IgE antibodies against autoantigens) and type IIb ...
Dennis, Wong +2 more
openaire +2 more sources

